Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Copenhagen
Clinical trial register · Denmark

Clinical Trials in Copenhagen, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2469 matching records held by the registry are in this view. Synced 16 Oct 2026, 03:17 UTC
2469
Studies in scope
all four open statuses
1395
Recruiting now
open to new participants
438
Lead sponsors
across recruiting studies
Top sites
Copenhagen 18 Aarhus N 11 Odense C 8 Roskilde 6 Esbjerg 6
Narrow the registerReset
Recruitment status
Phase
Site location
Copenhagen18 Aarhus N11 Odense C8 Roskilde6 Esbjerg6
All 20 locations
Target enrolment
to

Trials with a site in Copenhagen

18 of 2469 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Active, closed
Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments
NCT07468071Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer, Advanced Solid Tumors Harboring the KRAS G12C Mutation
Novartis Pharmaceuticals
Phase 1/2
25
Copenhagen
2026-06-08
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Aarhus N, Copenhagen, Esbjerg, Gistrup, Herlev, Roskilde, Viborg
2026-05-11
Recruiting
Novartis Pharmaceuticals
Phase 3
770
Copenhagen
2026-03-24
Recruiting
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
NCT06726148Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Extensive-stage Small Cell Lung Cancer
Novartis Pharmaceuticals
Phase 1/2
280
Copenhagen, Odense C
2025-04-03
Active, closed
Novartis Pharmaceuticals
Phase 3
146
Copenhagen
2024-07-31
Recruiting
Novartis Pharmaceuticals
Phase 3
106
Aarhus N, Copenhagen
2023-10-02
Active, closed
Novartis Pharmaceuticals
Phase 3
20
Copenhagen
2022-12-19
Recruiting
Asciminib Roll-over Study
NCT04877522Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Novartis Pharmaceuticals
Phase 4
347
Copenhagen
2022-08-30
Active, closed
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
NCT04971226Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
Novartis Pharmaceuticals
Phase 3
405
Aarhus N, Copenhagen
2021-10-06
Recruiting
Novartis Pharmaceuticals
Phase 3
540
Aalborg, Aarhus N, Copenhagen, Odense C
2021-09-20
Active, closed
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
NCT04699188KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small-Cell Lung, Carcinoma, Colorectal, Cancer of Lung
Novartis Pharmaceuticals
Phase 1/2
344
Copenhagen
2021-02-24
Active, closed
Pediatric Long-Term Follow-up and Rollover Study
NCT03975829Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood
Novartis Pharmaceuticals
Phase 4
163
Copenhagen
2019-11-04
Active, closed
Novartis Pharmaceuticals
Phase 2
121
Copenhagen
2019-06-24
Active, closed
Novartis Pharmaceuticals
Phase 2
248
Copenhagen, Roskilde
2019-02-27
Recruiting
Dabrafenib and/or Trametinib Rollover Study
NCT03340506Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers
Novartis Pharmaceuticals
Phase 4
100
Copenhagen
2018-01-26
Recruiting
CAR-T Long Term Follow Up (LTFU) Study
NCT02445222Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals
Phase 3
1,105
Copenhagen
2015-11-02
Rows per page Showing 1–18 of 18
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 October 2026. https://priyalifescience.com/clinical-trials-denmark/city/copenhagen

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,469 studies in total at the last sync on 16 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 18 of those studies with a site in Copenhagen that also match the filters currently applied.

How many clinical trials are recruiting in Copenhagen?

7 of the 18 studies on this page are recruiting new participants as of the 16 Oct 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 11 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Copenhagen), 18 studies
PhaseStudiesRecruitingShare
Phase 39450%
Phase 1/23116.7%
Phase 23016.7%
Phase 43216.7%

Most active sponsors

Lead sponsors with the most studies (Copenhagen)
Lead sponsorStudiesRecruiting
Novartis Pharmaceuticals187
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.